Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
Scientific Title
A Phase II of Single Agent Cabozantinib in Patients With Locally Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma Post Immunotherapy or Who Are Unsuitable for Immunotherapy